http://www.ncbi.nlm.nih.gov/pubmed/18618509

http://www.ncbi.nlm.nih.gov/pubmed/18591379

http://www.ncbi.nlm.nih.gov/pubmed/17989719

http://jco.ascopubs.org/cgi/content/abstract/26/1/96

http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=Retrieve&db=PubMed&list_uids=18184868&dopt=AbstractPlus

http://www.peerview-institute.org/news/content.nsf/PaperFrameSet?OpenForm&pp=1&id=EE8561B4F0547BCB85256BAB006EFE3E&refid=2078&specid=39&newsid=852571020057CCF6852573AB004BE6CE&locref=ntkwatch&u=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Abstract&list_uids=18064459

http://www.blackwell-synergy.com/doi/abs/10.1111/j.1440-1789.2007.00784.x

Cladribine in the treatment of IgM paraproteinemic polyneuropathy.

Cutaneous adverse reaction to 2-chlorodeoxyadenosine with histological flame figures in patients with chronic lymphocytic leukaemia.

Efficacy of continuous infusion 2-CDA (cladribine) in pediatric patients with Langerhans cell histiocytosis.